Nayeri, Fariba <br/><br/>
Hepatocyte growth factor may act as an early therapeutic predictor in pneumonia.  [electronic resource] 

 -  Scandinavian journal of infectious diseases  2002 
 - 500-4 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0036-5548 
<br/><br/><label>Standard No.: </label>10.1080/00365540110080890  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Anti-Bacterial Agents--therapeutic use<br/>C-Reactive Protein--metabolism<br/>Case-Control Studies<br/>Enzyme-Linked Immunosorbent Assay<br/>Female<br/>Hepatocyte Growth Factor--blood<br/>Humans<br/>Male<br/>Middle Aged<br/>Pneumonia--blood<br/>Predictive Value of Tests<br/>Prognosis